Whether the antibody-mediated inhibition of CTLA4 affects atherosclerosis is incompletely understood and nowadays is particularly relevant, as antagonistic CTLA4 antibodies are increasingly used in cancer patients. The gene discussed is CTLA4; the disease is atherosclerosis.